Summary
Neuro-oncologist Ingo Mellinghoff first became intrigued by scientific questions regarding brain tumors while working in the lab of physician-scientist Charles Sawyers before both came to MSK. Now, Dr. Mellinghoff leads MSK’s Department of Neurology as it deploys innovative technologies to understand how these cancers develop and progress.
When neuro-oncologist Ingo Mellinghoff was named Chair of Memorial Sloan Kettering’s Department of Neurology in October 2020, it marked the culmination of a career devoted to studying how cancer affects the brain. Dr. Mellinghoff previously served as Chief of the MSK Brain Tumor Service and Vice Chair of Research in the Department of Neurology as well as its Interim Chair. His research laboratory in the Human Oncology and Pathogenesis Program (HOPP) focuses on how faulty signals in brain cells can lead to the development and growth of brain tumors.